Explainers

Plain-English explanations of MEF2C research terms, concepts, and scientific mechanisms.

Inpart (Industry Partnering Platform)

**What it means:** Inpart is a **global scientific partnering platform** used by 90% of the world's top 50 pharmaceutical companies. Think of it as LinkedIn for drug development — it tracks which acad...

Longitudinal Data / Longitudinal Study

**What it means:** Longitudinal data is collected from the **same subjects repeatedly over time** — like taking photos of the same tree every year to watch it grow. This is different from a cross-sect...

Patient-Derived (in cell biology context)

**What it means:** "Patient-derived" means cells, tissues, or samples that were taken **directly from a patient** (usually via biopsy or blood draw) and used in research. This is different from cancer...

Preclinical Update (in gene therapy context)

**What it means:** "Preclinical" means research done **before human trials begin** — in cell cultures (in vitro) and animal models (in vivo). A "preclinical update" means the researchers have complete...

Oncology / Solid Tumor (in CDK2 inhibitor context)

**What it means:** Oncology is the branch of medicine that deals with cancer. "Solid tumors" are cancers that form actual lumps or masses (as opposed to blood cancers like leukemia). Breast, ovarian, ...

Oncologic Biomarker Context for MHS

**What it means:** A biomarker is a measurable biological indicator. In cancer, biomarkers (like ctDNA, tumor size on imaging, or protein levels in blood) tell doctors how the cancer is responding to ...

International Patent (WIPO/WO2026039331)

**What it means:** The WO2026039331 patent published through WIPO (World Intellectual Property Organization) covers the viral gene therapy approach for MEF2C. "WO" indicates a Patent Cooperation Treat...

Theripio Innovations (the startup)

**What it means:** Theripio Innovations is the **startup company** founded by Dr. Christopher Cowan at MUSC to commercialize the MEF2C RNA therapeutic platform. In drug development, when academic rese...

Clinical Readiness Study (vs. Clinical Trial)

**What it means:** A **"clinical readiness study"** is different from a full clinical trial. It's the work done *before* a trial to make sure the trial can actually happen. This includes: - **Patient ...

Drug Pipeline (in pharma context)

**What it means:** A "drug pipeline" is the entire journey a drug takes from the lab bench to the pharmacy shelf. Think of it as a factory assembly line: 1. **Discovery** → finding compounds that affe...

First-in-Human (FIH) Trial

**What it means:** This is the **very first time a drug is given to people** — never humans before, only animals (and cell cultures). It's essentially Phase 1a. The goals are: 1. **Safety** — does the...

Microglial Synaptic Pruning

**What it means:** During brain development, the brain makes way more synaptic connections than it needs — like building more roads than necessary. **Microglia** (the brain's immune cells) act as "pru...

Fc-gamma Receptor Signaling

**What it means:** Fc-gamma receptors are "antenna" proteins on microglia that detect antibodies attached to targets (like synaptic connections). When an antibody flags a synapse, the Fc-gamma recepto...

Blood-Brain Barrier (BBB) Penetrance

The Blood-Brain Barrier (BBB) is like a **military checkpoint** between your bloodstream and your brain. It's made of tightly packed cells with no gaps — designed to keep toxins out. But it also keeps...

Behavioral Brain Research Foundation (BDRF)

**What it means:** The BDRF is a **private foundation** that funds neuroscience research. Their "Distinguished Investigative Grant" is a significant award given to researchers who have demonstrated ex...

Germline Mosaicism (rare inheritance mechanism)

**What it means:** Germline mosaicism is a rare phenomenon where a parent has a mutation in some of their reproductive cells (sperm or eggs) but NOT in their body cells. This means the parent tested "...

WIPO Patent Cooperation Treaty (PCT)

**What it means:** Think of the PCT as a "global patent application portal." Instead of filing separate patents in 100+ countries individually, inventors file **one application** that reserves their p...

ADAMDEC1 (and why it matters)

**What it means:** ADAMDEC1 is a **metalloprotease** — a protein-cutting enzyme that remodels the **extracellular matrix** (the structural scaffolding that holds brain cells in place). Think of it as ...

CARD11 (and why it matters)

**What it means:** CARD11 is a **scaffold protein** — it acts like a docking station that brings inflammatory signaling molecules together. When a microglial receptor detects a threat, CARD11 assemble...

De Novo Mutation

**What it means:** A de novo (Latin for "from new") mutation is a genetic change that occurs **for the first time** in a person — it wasn't inherited from either parent. The parents' DNA is normal; th...

AAV (Adeno-Associated Virus)

**What it means:** AAV is a tiny, harmless virus used as a **delivery vehicle** (vector) to carry therapeutic genes into cells. Think of it like a Trojan horse — the virus looks normal from the outsid...

Isogenic (in stem cell research)

**What it means:** "Isogenic" cells are cells that are **genetically identical except for one specific difference** — like twin siblings where one has a targeted mutation and the other doesn't. Resear...

EpiSign (Methylation Defects testing platform)

**What it means:** EpiSign is a commercial testing platform that analyzes genome-wide DNA methylation patterns to identify disease-specific "epigenetic signatures." It's like a fingerprint — each gene...

PFS (Progression-Free Survival)

**What it means:** PFS is a common clinical trial metric. It measures **how long patients live without their disease getting worse** — specifically, without the cancer growing or spreading. It's measu...

Phase 1a/b Clinical Trial

**What the phases mean:** - **Phase 1a:** First-in-human testing. The primary goal is **safety** — "Is this drug safe in humans at all?" A small group of patients receives escalating doses to find the...

KRAS and BRAF (signaling pathways in MEF2C context)

**What it means:** KRAS and BRAF are genes that code for proteins in the **MAPK/ERK signaling pathway** — a cellular "messaging chain" that tells cells to grow, divide, and differentiate. In some case...

MEF2 (the family, not just MEF2C)

**What it means:** MEF2C is one member of a family of four related transcription factors: MEF2A, MEF2B, MEF2C, and MEF2D. They all share a similar DNA-binding domain (the "MADS-box"), which is why the...

Transcription Factor

**What it means:** Imagine your DNA is a library of instruction manuals (genes). A transcription factor is like a **foreman** who walks through the library, finds the right manual, and tells the worke...

KRAS Mutation and RASopathies

**What it means:** KRAS is one of the most commonly mutated genes in cancer. "RASopathies" are a group of genetic conditions caused by mutations in the RAS signaling pathway (which includes genes like...

ctDNA (Circulating Tumor DNA)

**What it means:** Tumors shed tiny fragments of their DNA into the bloodstream — this is "circulating tumor DNA." By measuring ctDNA levels in a blood draw (a "liquid biopsy"), doctors can track canc...

iPSC (Induced Pluripotent Stem Cell)

**What it means:** iPSCs are adult cells (like skin cells) that have been **reprogrammed** back to an embryonic-like state — they can become any cell type in the body. It's like hitting the "reset but...

CDK4/6 Inhibitor (related to MHS research)

**What it means:** CDK4 and CDK6 are proteins closely related to CDK2. They all work together to drive cell division. CDK4/6 inhibitors (like palbociclib, ribociclib, abemaciclib) are already FDA-appr...

Retinal (eye) in the context of gene therapy

**What it means:** The retina (the light-sensitive layer at the back of the eye) was actually the **first tissue** where gene therapy succeeded (Luxturna, 2017). The eye is "immune-privileged" — meani...

Microdeletion (5q14.3)

**What it means:** A microdeletion is a small chunk of DNA that's been deleted — typically too small to see under a microscope but large enough to remove several genes. "5q14.3" is the specific chromo...

MEF2C-Het (mouse model nomenclature)

**What it means:** "Het" is shorthand for "heterozygous." So Mef2c-Het means mice that have one normal copy of the mouse version of the MEF2C gene (Mef2c, lowercase in mice) and one broken copy. This ...

PSD-95 (DLG4)

**What it means:** PSD-95 (encoded by the DLG4 gene) is a **scaffolding protein** located at the synapse. It acts like the structural framework of a building, holding receptors, signaling molecules, a...

GRIN2B (NMDA Receptor)

**What it means:** GRIN2B (also known as NR2B) is a subunit of the **NMDA-type glutamate receptor**, which is critical for synaptic plasticity — the brain's ability to strengthen or weaken connections...

MADS-Box (DNA-binding domain)

**What it means:** The MADS-box is a ~58 amino acid DNA-binding domain — a specific region of the MEF2C protein that acts like a **grip** or **claw** that grabs onto specific DNA sequences. It's the p...

Base Editing

**What it means:** Base editing is a precise gene-editing technique that changes a single DNA letter (like turning an A into a G) without cutting both strands of the DNA helix (which is how traditiona...

Natural History Study

**What it means:** A natural history study systematically tracks a disease **without giving any treatment**. It's like creating a detailed map of a territory before you try to change it — you need to ...

PROTAC (Proteolysis-Targeting Chimaera)

**What it means:** PROTACs are a **completely different class of drug** from traditional inhibitors. Traditional inhibitors work like a cork in a bottle — they block a protein's function while the dru...

Blood-Brain Barrier (BBB)

**What it means:** The BBB is an ultra-tight layer of cells lining the brain's blood vessels. Think of it like a **super-filter** or a nightclub with an extremely strict bouncer — it lets nutrients an...